Condition
Hernioplasty
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (4)
P 1 (1)
P 2 (1)
Trial Status
Completed5
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07252817Not ApplicableCompletedPrimary
Intensive Monitoring of Post-surgery Pain in Major Ambulatory Surgery
NCT07111702Not ApplicableCompleted
Prophylactic Antibiotics in Groin Hernioplasty
NCT06327763Not ApplicableCompleted
Prophylactic Ilioinguinal Neurectomy During Open Tension-Free Inguinal Hernia Repair
NCT06258317Not ApplicableNot Yet Recruiting
Mesh Fixation Versus Non Fixation in Laparoscopic Inguinal Hernioplasty
NCT03234374Phase 1CompletedPrimary
Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty
NCT02232178Phase 2CompletedPrimary
Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant
Showing all 6 trials